Sustainable Innovation ILS Automation demonstrates a strong focus on process industry automation with specialized control systems for bioreactors and fermentation processes, positioning it well to serve biotech and pharmaceutical clients seeking reliable, tailored automation solutions.

Recent Acquisition The recent acquisition by DCI Inc. suggests potential opportunities for cross-selling additional automation services and integration solutions within DCI’s client base, expanding ILS's market reach and project pipeline.

Niche Expertise With a background in real-time, rule-based systems and custom SCADA applications, ILS offers specialized services that appeal to companies requiring highly customized automation and control systems, especially in complex manufacturing and process environments.

Technological Integration ILS’s expertise in integrating laboratory control systems with SCADA platforms indicates opportunities to target industries investing in digital transformation, automation modernization, and advanced process control technologies.

Growth Potential Although a smaller player with revenues under 10 million dollars, ILS’s focus on innovative bioprocess control hardware and software, along with its recent achievements, positions it for growth within the expanding biotech and process automation sectors.